![](/img/cover-not-exists.png)
Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma
Chowdhry, Amit K., Hardy, Sara J., Milano, Michael T.Volume:
7
Journal:
Annals of Translational Medicine
DOI:
10.21037/atm.2019.09.10
Date:
December, 2019
File:
PDF, 128 KB
2019